Draft directions paper released
Senator Kim Carr, Minister for Innovation, Industry, Science and Research, today welcomed the release of the draft directions paper from the Pharmaceuticals Industry Strategy Group.
"I thank the Strategy Group for this draft directions paper. I'm glad to see that the pharmaceuticals industry has been able to come together to develop a ten year plan to attract investment in R&D, clinical trials and manufacturing activity in Australia.
"The group has provided a number of recommendations as to how the Government, industry, and workers can combine our efforts to shape the future for pharmaceuticals in Australia," Senator Carr said.
The Strategy Group, made up of key industry and union leaders, has worked together to generate new ideas about a sustainable future, focusing on the things that Australia does best, world class research and development, and a strong focus on high quality manufacturing capabilities.
"I am glad the Strategy Group sees Australia as having the potential to build on its strengths, to create a sustainable future around high quality R&D, clinical trials and specialist manufacturing," Senator Carr said.
The Strategy Group is due to submit the final report at the end of the year.
"I look forward to the Group road testing these ideas in the coming months, and endorse further discussions with other industry players."
The Draft Directions Paper can be viewed here.
Media contact: Catriona Jackson, Minister's Office, 0417 142 238